ANNOUNCEMENT ON CE APPROVAL FOR COVID-19 ANTIGEN RAPID TEST KIT (Saliva) SELF-TESTING


The COVID-19 Antigen Rapid Test (Saliva) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19.

This test is intended for home use with self-collected saliva samples in individuals aged 18 and older.  Sampling from anyone under the age of 18 should be performed under the guidance of an adult. People who are unable to carry out the test on their own should seek support. 

This test utilizes the lateral flow immunoassay technology for the detection of nucleocapsid protein antigen in individuals with known or suspected COVID-19.

Positive results are indicative of the presence of SARS-CoV-2. Individuals who test positive should self-isolate and seek additional care from their healthcare provider. Positive results do not rule out bacterial infection or co-infection with other viruses.

Negative results do not preclude SARS-CoV-2 infection. Individuals who test negative and continue to experience COVID-like symptoms should seek follow up care from their healthcare provider.


Package Available: 1Test/Box; 25Tests/Box

Welcome to inquire for details!


2022.4.25修改 产品宣传页_00.jpg




  • ·Company News

    Congratulations to UK CTDA approval of our Safecare Covid-19 antigen Rapid Test Kit (For Self-testing)

  • ·Company News

    Congratulations to Safecare Biotech for Geting CE Approval of Monkeypox Virus Test

  • ·Company News

    Congratulations to CE Approval for Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test( Self-testing)

  • ·Company News

    Safecare SARS-CoV-2 Nucleic Acid Detection Kit get CE approval! ! !

  • ·Company News

    Declaration of Conformity about our products!

Time:2022/04/18
Classification:Company News

NEWS

National High-tech Enterprise

Location:HOME>Company News

TEL:  

 

MAIL:

   

Add: 

 

+86 571 81389219

 

admin@safecare.com.cn

 

Bldg 2, No 2628 Yuhangtang RD,Hangzhou, 311121 China

CONTACT US

CONTACT US

Leave us instant  message

Follow us on